Cargando…

CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma

SIMPLE SUMMARY: CircRNAs are involved in the tumorigenesis and metastasis of hepatocellular carcinoma (HCC). Previous studies revealed that circRNA expression was associated with 3′-end splicing. As the core executor of 3′-end cleavage, CPSF3 should modulate the circularization of circRNAs. From our...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Ying, Ji, Haofei, Dong, Jiani, Wang, Xueying, He, Zhilin, Cheng, Zeneng, Zhu, Qubo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452738/
https://www.ncbi.nlm.nih.gov/pubmed/37627085
http://dx.doi.org/10.3390/cancers15164057
Descripción
Sumario:SIMPLE SUMMARY: CircRNAs are involved in the tumorigenesis and metastasis of hepatocellular carcinoma (HCC). Previous studies revealed that circRNA expression was associated with 3′-end splicing. As the core executor of 3′-end cleavage, CPSF3 should modulate the circularization of circRNAs. From our research, we found that CPSF3 was highly expressed in HCC cells, and a high CPSF3 level was predictive of a poor prognosis. The increase of CPSF3 promoted the conversion of pre-mRNA processing products from circRNA to linear mRNA, thus inducing the tumorigenesis and metastasis of HCC. JTE-607, which is a chemical inhibitor of CPSF3, exerted a therapeutic effect on HCC. This elaborate work not only sheds a light on the research about the initiation and progression of HCC, but also contributes to the diagnosis and treatment of HCC. ABSTRACT: CircRNAs are crucial in tumorigenesis and metastasis, and are comprehensively downregulated in hepatocellular carcinoma (HCC). Previous studies demonstrated that the back-splicing of circRNAs was closely related to 3′-end splicing. As a core executor of 3′-end cleavage, we hypothesized that CPSF3 modulated circRNA circularization. Clinical data were analyzed to establish the prognostic correlations. Cytological experiments were performed to determine the role of CPSF3 in HCC. A fluorescent reporter was employed to explore the back-splicing mechanism. The circRNAs regulated by CPSF3 were screened by RNA-seq and validated by PCR, and changes in downstream pathways were explored by molecular experiments. Finally, the safety and efficacy of the CPSF3 inhibitor JTE-607 were verified both in vitro and in vivo. The results showed that CPSF3 was highly expressed in HCC cells, promoting their proliferation and migration, and that a high CPSF3 level was predictive of a poor prognosis. A mechanistic study revealed that CPSF3 enhanced RNA cleavage, thereby reducing circRNAs, and increasing linear mRNAs. Furthermore, inhibition of CPSF3 by JET-607 suppressed the proliferation of HCC cells. Our findings indicate that the increase of CPSF3 in HCC promotes the shift of pre-mRNA from circRNA to linear mRNA, leading to uncontrolled cell proliferation. JTE-607 exerted a therapeutic effect on HCC by blocking CPSF3.